CDPHP created the “Inside Look: A Call for Rx Transparency” website in order to educate consumers about drug costs, and motivate people to price drugs in a more rational fashion, said John Bennett, MD, FACC, FACP, president and CEO of CDPHP.
CDPHP created the “Inside Look: A Call for Rx Transparency” website in order to educate consumers about drug costs, and motivate people to price drugs in a more rational fashion, said John Bennett, MD, FACC, FACP, president and CEO of CDPHP.
Transcript (modified)
Why was the Inside Look: A Call for Rx Transparency website created and how does it benefit consumers?
We think it’s very important at this point that consumers be educated around the real problems around drug costs. And the real problems are the price of the drugs. We have some very effective and exciting medications which can change people’s lives, and save their lives in many cases. But these drugs are useless if no one can afford them.
And so we feel that the first step is educating our consumers as to what those real issues are and we believe in transparency in drug pricing. We believe that people need to come clean, that the pharmaceutical industry, in particular, needs to come clean and show what their costs of production really are so that we can get to a much more rational pricing of drugs, as opposed to the pure profit-taking that we have today.
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More